MEDGm vs Tell Her Doc

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MEDGm

Affiliate partner

Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.

Semaglutide / month: $299/moMonth-to-month (the advertised $179 is the first month only, after an automatically applied coupon)
Tirzepatide / month: $399/moMonth-to-month (the advertised $279 is the first month only)

Index 67/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check MEDGm pricing Read review

Tell Her Doc

Provider comparison

Women who want a well-documented, LegitScript-verified provider and will get the real recurring price before trusting the $269 headline.

Semaglutide / month: $269/moCompounded oral
Tirzepatide / month: Not disclosed

Index 69/100 · Grade CChecked August 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Tell Her Doc pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Tell Her Doc has the higher Cost-Efficiency Index: 69/100 versus 67/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MEDGm

Tell Her Doc

Semaglutide / month: MEDGm: $299/moMonth-to-month (the advertised $179 is the first month only, after an automatically applied coupon); Tell Her Doc: $269/moCompounded oral

Tirzepatide / month: MEDGm: $399/moMonth-to-month (the advertised $279 is the first month only); Tell Her Doc: Not disclosed

Semaglutide / year (modeled): MEDGm: $3,588; Tell Her Doc: $3,228

Tirzepatide / year (modeled): MEDGm: $4,788; Tell Her Doc: —

State availability: MEDGm: All 50 states; Tell Her Doc: All 50 states

Oral / sublingual option listed: MEDGm: Yes; Tell Her Doc: Yes

Brand-name access listed: MEDGm: Yes; Tell Her Doc: Yes

Provider facts checked: MEDGm: October 2026; Tell Her Doc: August 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MEDGm

Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.

Reasons to consider it

Names all four pharmacy partners in its terms, with street addresses, phone numbers and websites, and says which compounding classes they operate under
Names seven prescribing professional corporations on its consent page rather than referring to an unnamed medical group
Prices three GLP-1 routes — semaglutide injection, semaglutide tablet and tirzepatide — at one, three, six and twelve months, all on the public product pages before any intake

What to weigh up

The GLP-1 page's "Starting at $169" is the twelve-month rate paid upfront ($2,028), and the $179 that follows it is a first-month coupon price; month to month, semaglutide injections cost $299, tablets $369 and tirzepatide $399
The treatments FAQ says "your price never increases" on a plan whose price increases by $120 at the first renewal
The twelve-month bundle is charged upfront, renews for another full upfront year up to ten days early, and none of it is refundable once charged

Compounded drugs are not FDA-approved. Understand the medication options.

Check MEDGm pricing Read the full MEDGm review

Tell Her Doc

Women who want a well-documented, LegitScript-verified provider and will get the real recurring price before trusting the $269 headline.

Reasons to consider it

Four named, NPI-verified physicians -- unusually transparent medical leadership for this category
Four named compounding pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
Claims and displays coverage across all 50 states

What to weigh up

Headline '$269 / $140 off' price is a prepaid, first-time-customer, oral-semaglutide-only promo -- not a general or recurring rate
No standalone tirzepatide price disclosed
Fine print restricting the discount is not visible from the homepage banner alone

Compounded drugs are not FDA-approved. Understand the medication options.

Check Tell Her Doc pricing Read the full Tell Her Doc review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MEDGmTell Her Doc

Normalized Cost/Month: MEDGm:
41/100; Tell Her Doc:
45/100

Price Transparency: MEDGm:
60/100; Tell Her Doc:
78/100

Nationwide Access: MEDGm:
86/100; Tell Her Doc:
86/100

Formulation Options: MEDGm:
90/100; Tell Her Doc:
77/100

Clinical Oversight: MEDGm:
73/100; Tell Her Doc:
76/100

Contract Flexibility: MEDGm:
67/100; Tell Her Doc:
61/100

Before you sign up

Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to MEDGm Alternatives to Tell Her Doc

More provider matchups

CoreAge Rx vs MEDGm CoreAge Rx vs Tell Her Doc

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.